regulatory_compliance

MTD for Income Tax to Cover 2.9 Million UK Sole Traders by 2028

Image
MTD for Income Tax to Cover 2.9 Million UK Sole Traders by 2028

Stansted, England – September 09, 2026 -- Making Tax Digital for Income Tax will expand to roughly 2.9 million UK sole traders and landlords by April 2028 as HMRC lowers the qualifying-income threshold in stages, according to an analysis by Your Ecommerce Accountant based on HMRC's 2023-24 business-population data.

864,000 taxpayers entered the first mandatory phase in April 2026

HMRC data shows 864,000 individuals with qualifying self-employment or property income above £50,000 became subject to mandatory MTD for Income Tax from 6 April 2026. This group is now operating within its first mandatory tax year, having previously prepared for the rules rather than complied with them.

MMRO Earns URAC AI in Health Care Accreditation

Novi, Mich. – September 09, 2026 -- Managed Medical Review Organization, Inc. (MMRO) has earned URAC's Artificial Intelligence in Health Care Accreditation (Version 1.0), the first accreditation program in the U.S. to set standards for responsible AI use and development in healthcare.

MMRO built a year-long AI governance program to meet URAC's framework

The program includes responsible-use policies, risk and impact assessments addressing AI-specific data security challenges, and testing and training requirements, with formal clinical oversight from MMRO's Vice President of Clinical Programs, Jen Mongeau, DHA, MBA, MSN, RN.

SDK.finance Launches Standalone Real-Time General Ledger for FinTechs

Image
SDK.finance Launches Standalone Real-Time General Ledger for FinTechs

Vilnius, Lithuania – September 09, 2026 -- SDK.finance has launched SDK.finance General Ledger, a standalone real-time accounting module designed for banks, electronic money institutions (EMIs), payment service providers (PSPs) and other financial businesses running complex, multi-rail products.

New module converts business events into balanced double-entry journal entries automatically

The event-driven system consumes transaction data from an existing core banking system, payment platform, digital wallet or other transaction engine and translates it into balanced double-entry journal entries using configurable accounting determinations and mapping rules. Entries are validated for debit-credit balance, posted automatically when configured, and used to update account balances and turnovers in real time.

BLUETTI Convenes IFA 2026 Panel on Connected Home Energy Systems

Image
BLUETTI Convenes IFA 2026 Panel on Connected Home Energy Systems

Berlin – September 08, 2026 -- BLUETTI brought together executives from BSW-Solar, Shelly Group, Flatpeak and pv magazine at IFA 2026 to debate how real-time data and artificial intelligence are converting standalone solar and storage products into integrated home energy systems.

Panelists call for open standards to scale balcony solar and home batteries

Speakers argued that balcony photovoltaic units, home battery storage and smart home devices now let households generate, store and manage energy closer to the point of consumption. They said broader adoption depends on open integration standards, reliable data exchange and favorable market conditions.

BLUETTI, BSW-Solar, Shelly Group Push Open Standards at IFA 2026

Image
BLUETTI, BSW-Solar, Shelly Group Push Open Standards at IFA 2026

Berlin – September 08, 2026 -- BLUETTI convened executives from BSW-Solar, Shelly Group, Flatpeak and pv magazine at IFA 2026 to press the case for open integration standards that turn household solar, storage and smart-device hardware into unified energy systems.

Industry leaders call for open data exchange to accelerate smart-home energy adoption

The panel, titled "Energy. Value. Future. - From Power Supply to Smarter Living," examined how balcony solar panels, home battery storage and connected devices are shifting households from passive consumers to active participants in energy markets. Speakers argued that reliable data exchange and supportive market frameworks are prerequisites for scaling adoption beyond early adopters.

Cooking Oil Theft Hits $500M as Biodiesel Firm Warns Restaurants

Buffalo, N.Y. – September 08, 2026 -- Used cooking oil theft across the United States totaled between $300 million and $500 million in 2025, according to the North American Renderers Association, prompting Buffalo Biodiesel to issue a security warning to its roughly 30,000 restaurant customers across western New York and the Northeast.

Buffalo Biodiesel says hundreds of thefts have hit its customer base and the trend is accelerating

Ryan Haggerty, chief state litigator and general counsel at Buffalo Biodiesel, said restaurants are frequent targets because used cooking oil bins are typically stored outdoors in unlit, unmonitored areas. "Cooking oil theft nationally has become a big problem and there is a sophisticated and growing illegal black marketplace that is threatening the biodiesel sector," Haggerty said.

Teadit's Sold-Out PCC-1 Training Draws Record Turnout in Pasadena

Image
Teadit's Sold-Out PCC-1 Training Draws Record Turnout in Pasadena

Pasadena, Texas – September 08, 2026 -- Teadit hosted a sold-out two-day training course this week at its Pasadena, TX facility, drawing record attendance from local operators and engineers.

Course targets flange sealing engineering under ASME PCC-1 standard

The session, titled "Do You Really Understand the Engineering of Flange Sealing and ASME PCC-1?", covered sealing fundamentals and the interaction between gaskets, fasteners, and flanges in joint performance. Teadit's Engineering Manager Dale Norman and Applications Engineer Francisco Duque led the course, focusing on balancing minimum and maximum gasket stress, bolt stress, and flange stress to achieve effective seals.

"One of the key takeaways from this course was learning how to balance these forces to achieve an effective seal," said Norman.

Mabwell's 9MW1911 Cuts Severe COPD Exacerbations by 100% at High Dose

Shanghai – September 08, 2026 -- Mabwell (688062.SH, 02493.HK) reported that its anti-ST2 monoclonal antibody 9MW1911 reduced the annualized rate of severe COPD exacerbations by 100% in the 900 mg dose group compared with placebo, according to Phase Ib/IIa data presented as a poster at the European Respiratory Society International Congress 2026 (ERS 2026).

Trial enrolled 80 COPD patients across four dose arms

The randomized, double-blind, placebo-controlled study (9MW1911-C03) enrolled 80 former smokers with moderate-to-severe COPD, randomizing participants to intravenous 9MW1911 at 100 mg, 300 mg, 600 mg, or 900 mg, or placebo, every four weeks. Most participants had blood eosinophil counts of 300 cells/μL or below.

Baden-Württemberg Launches Action Plan for Self-Medication Policy

Image
Baden-Württemberg Launches Action Plan for Self-Medication Policy

Stuttgart – September 08, 2026 -- Pharma Deutschland's Baden-Württemberg chapter and MEDIVERBUND AG kicked off development of a regional action plan aimed at strengthening self-medication as a lever to relieve pressure on doctors' offices and build a more resilient healthcare system.

Industry and physician groups agree self-medication can free up doctor capacity

At the "Selbstverständlich Selbstmedikation" event, representatives from politics, medicine, pharmacies, health insurers and the pharmaceutical industry discussed conditions needed to expand patient self-treatment for minor ailments. Dr. Traugott Ullrich, chairman of Pharma Deutschland's Baden-Württemberg association, argued that low-threshold self-medication allows patients to treat or prevent minor health issues while pharmacies handle counseling and physicians retain capacity for more complex cases.

Acepodia Wins FDA Clearance for Dual-Payload ADC ACE723 in Liver Cancer

Alameda, Calif. – September 08, 2026 -- Acepodia (6976: TT) said the U.S. Food and Drug Administration has cleared its Investigational New Drug application for ACE723, a GPC3-targeted dual-payload antibody-drug conjugate, clearing the way for a Phase 1 clinical trial in unresectable or metastatic hepatocellular carcinoma (HCC).

FDA clearance advances first candidate from Acepodia's AD2C platform into human trials

ACE723 is built on Acepodia's proprietary Antibody-Dual-Drugs Conjugation (AD2C) platform, which combines antibody engineering, medicinal chemistry and tumor biology to deliver two cytotoxic payloads to a single tumor-targeting antibody. The compound targets GPC3, a tumor-associated antigen frequently expressed in HCC tumor cells.